Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,665Revenue $M2,266Net Margin (%)6.7Altman Z-Score4.4
Enterprise Value $M3,752EPS $2.3Operating Margin %9.5Piotroski F-Score7
P/E(ttm)24.1Beneish M-Score-2.7Pre-tax Margin (%)9.5Higher ROA y-yY
Price/Book6.010-y EBITDA Growth Rate %16.6Quick Ratio1.7Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %14.7Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow29.4y-y EBITDA Growth Rate %18.8ROA % (ttm)8.5Higher Current Ratio y-yY
Dividend Yield %--PEG1.7ROE % (ttm)25.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M55.2ROIC % (ttm)23.4Gross Margin Increase y-yY

Gurus Latest Trades with PRXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRXLJoel Greenblatt 2015-03-31 Reduce-0.08%$55.94 - $70.12
($63.74)
$ 66.164%Reduce 12.74%1,265,994
PRXLVanguard Health Care Fund 2015-03-31 Reduce-0.07%$55.94 - $70.12
($63.74)
$ 66.164%Reduce 11.70%3,790,200
PRXLKen Fisher 2015-03-31 Reduce$55.94 - $70.12
($63.74)
$ 66.164%Reduce 0.65%2,439,694
PRXLJoel Greenblatt 2014-12-31 Add0.3%$52.86 - $64.01
($57.63)
$ 66.1615%Add 87.36%1,450,825
PRXLVanguard Health Care Fund 2014-12-31 Reduce-0.13%$52.86 - $64.01
($57.7)
$ 66.1615%Reduce 15.46%4,292,200
PRXLJoel Greenblatt 2014-09-30 Add0.31%$52.97 - $64.26
($57.05)
$ 66.1616%Add 169.71%774,370
PRXLJoel Greenblatt 2014-06-30 Add0.12%$43.94 - $55.47
($50.11)
$ 66.1632%Add 177.29%287,113
PRXLVanguard Health Care Fund 2014-06-30 Add0.04%$43.94 - $55.47
($50.22)
$ 66.1632%Add 5.65%5,077,400
PRXLKen Fisher 2014-06-30 Reduce-0.01%$43.94 - $55.47
($50.22)
$ 66.1632%Reduce 2.32%2,475,274
PRXLJoel Greenblatt 2014-03-31 Add0.07%$45.18 - $56.94
($51.01)
$ 66.1630%Add 361.66%103,542
PRXLVanguard Health Care Fund 2013-12-31 Add0.26%$38.93 - $54.85
($45.69)
$ 66.1645%Add 63.66%4,805,700
PRXLJoel Greenblatt 2013-12-31 Reduce-0.04%$38.93 - $54.85
($45.69)
$ 66.1645%Reduce 51.75%22,428
PRXLJoel Greenblatt 2013-09-30 Reduce-0.12%$46.43 - $51.33
($48.98)
$ 66.1635%Reduce 57.22%46,486
PRXLVanguard Health Care Fund 2013-06-30 Add0.06%$38.89 - $48.56
($43.94)
$ 66.1651%Add 13.36%2,936,400
PRXLJoel Greenblatt 2013-06-30 Reduce-0.01%$38.89 - $48.56
($43.94)
$ 66.1651%Reduce 5.96%108,668
PRXLKen Fisher 2013-06-30 Reduce$38.89 - $48.56
($43.94)
$ 66.1651%Reduce 0.02%2,649,794
PRXLJoel Greenblatt 2013-03-31 Reduce-0.07%$29.59 - $39.54
($34.89)
$ 66.1690%Reduce 25.52%115,560
PRXLJoel Greenblatt 2012-12-31 Add0.03%$29.07 - $32.61
($31.04)
$ 66.16113%Add 11.20%155,153
PRXLVanguard Health Care Fund 2012-12-31 Reduce-0.01%$29.07 - $32.61
($31.04)
$ 66.16113%Reduce 3.72%2,590,400
PRXLKen Fisher 2012-12-31 Reduce$29.07 - $32.61
($31.04)
$ 66.16113%Reduce 1.21%2,557,992
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PRXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOVE RICHARD LDirector 2015-05-14Sell5,000$651.78view
GOLDBERG MARK APresident & COO 2015-03-19Sell12,884$68.99-4.1view
CALLOW A DANA JRDirector 2015-03-02Sell2,000$65.840.49view
LINDOP CHRISTOPHER JDirector 2015-02-19Sell2,000$63.594.04view
VON RICKENBACH JOSEF HChairman & CEO 2015-02-13Sell65,100$62.535.81view
Holdener Eduard E.Director 2015-02-06Sell3,000$62.975.07view
BATT DOUGLAS ASVP, General Counsel & Sec. 2015-02-04Sell8,300$60.898.65view
Saarony GadiCorp. Sr. VP, CRS 2015-02-03Sell8,525$60.978.51view
Tsuetaki Tracy KenSVP, PCMS and PACE 2014-12-12Buy455$54.4721.46view
GOLDBERG MARK APresident & COO 2014-12-03Sell25,345$58.9912.15view

Press Releases about PRXL :

    Quarterly/Annual Reports about PRXL:

    News about PRXL:

    Articles On GuruFocus.com
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 12,920 Shares Mar 11 2011 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 1,500 Shares Mar 11 2011 
    PAREXEL International Corp. Reports Operating Results (10-Q) Feb 09 2011 
    PAREXEL International Corp. Reports Operating Results (10-Q) Nov 09 2010 
    PAREXEL International Corp. Reports Operating Results (10-K/A) Sep 09 2010 
    PAREXEL International Corp. Reports Operating Results (10-K) Aug 27 2010 
    PAREXEL International Corp. Reports Operating Results (10-Q) May 07 2010 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 13,149 Shares Mar 12 2010 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 15,600 Shares Mar 04 2010 

    More From Other Websites
    PAREXEL Enhances ClinPhone® RTSM Service to Simplify and Expedite Randomization and Trial Supply... May 27 2015
    PAREXEL International To Present At Goldman Sachs Healthcare Conference May 26 2015
    PAREXEL International To Present At Goldman Sachs Healthcare Conference May 26 2015
    PAREXEL Q3 Earnings in Line; FY15 Top-line View Trimmed - Analyst Blog May 06 2015
    PAREXEL International to Present at UBS Healthcare Conference May 04 2015
    PAREXEL International to Present at UBS Healthcare Conference May 04 2015
    10-Q for PAREXEL International Corp. May 03 2015
    PAREXEL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report May 01 2015
    PAREXEL International Corp Earnings Call scheduled for 10:00 am ET today Apr 30 2015
    PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 30 2015
    PAREXEL International Reports Third Quarter Fiscal Year 2015 Results Apr 29 2015
    Parexel meets 3Q profit forecasts Apr 29 2015
    Parexel meets 3Q profit forecasts Apr 29 2015
    PAREXEL International Reports Third Quarter Fiscal Year 2015 Results Apr 29 2015
    Q3 2015 PAREXEL International Corp Earnings Release - After Market Close Apr 29 2015
    Jefferies Previews Booming Biotech Earnings Apr 27 2015
    PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials Apr 24 2015
    PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Other Events Apr 14 2015
    PAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications Apr 13 2015
    PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy... Apr 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK